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Abstract: By modulating important properties of eukaryotic cells, many bacterial protein 
toxins highjack host signalling pathways to create a suitable niche for the pathogen to 
colonize and persist. Helicobacter pylori VacA is paradigm of pore-forming toxins which 
contributes to the pathogenesis of peptic ulceration. Several cellular receptors have been 
described for VacA, which exert different effects on epithelial and immune cells. The 
crystal structure of VacA p55 subunit might be important for elucidating details of receptor 
interaction and pore formation. Here we discuss the multiple signalling activities of this 
important toxin and the molecular crosstalk between VacA and other virulence factors. 
Keywords: Helicobacter pylori; signalling; type IV secretion; CagA; pathogenicity island; 
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1. Introduction 
Helicobacter pylori (Hp) is a highly successful pathogen that is estimated to persistently colonize 
the stomach of about half of the human world population. This bacterium has been recognized as the 
causative agent of chronic gastric inflammation, peptic ulcer disease, mucosa-associated lymphoid 
tissue (MALT) lymphoma or gastric cancer [1–6]. The clinical outcome of Hp infections is determined 
by a complex scenario of host-pathogen interactions. The cellular and molecular mechanisms used by 
Hp to subvert host defences have been investigated intensively over the last few years. Disease 
development is dependent on several parameters including both the genotype of the bacteria and 
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genetic predisposition of the host, as well as environmental factors [7–12]. Hp isolates from different 
geographical origin are surprisingly diverse both in their genome sequences and their pathogenicity. 
Dozens of bacterial factors have been shown to influence Hp pathogenesis including the flagella, 
urease, catalase, neutrophil-activating
  protein NapA, peptidoglycan, several
  adhesins (e.g., SabA, 
BabA, AlpA/B, OipA) and many others [1,13–16]. They can be classified as colonization factors (also 
called pathogenicity-associated factors) and virulence factors having direct cell-damaging capabilities. 
However, the two major disease-associated components are the vacuolating cytotoxin (VacA) and the 
cag (cytotoxin-associated genes) pathogenicity island (cagPAI). The gene encoding vacA is present in 
virtually all Hp strains, which suggests that the production of VacA plays an important role in the 
colonization or persistence of Hp in the human stomach [1,7–9,17]. The cagPAI is a 40 kb stretch of 
DNA, which was acquired by a horizontal DNA transfer event from yet unknown donor, and encodes 
components of a sophisticated type IV secretion system (T4SS). This T4SS forms a pilus for the 
injection of virulence factors into host target cells such as the CagA effector protein [7,11,12,18–20]. 
Injected CagA mimics a host cell protein in binding and activation of multiple signalling factors and 
induces actin-cytoskeletal rearrangements (cell elongation), disruption of cell-to-cell junctions (cell 
scattering) as well as proliferative, pro-inflammatory and anti-apoptotic nuclear responses [11,20–23]. 
In addition, Hp induces several T4SS-dependent but CagA-independent signalling events such as the 
activation of epidermal growth factor receptor EGFR [24,25] and the small Rho GTPase Rac1 [26–28]. 
The role of CagA and the T4SS have been discussed in numerous recent reviews [7,11,12,20]. Here we 
review the recent findings on the VacA structure and the various pathways how VacA highjacks host 
cell signalling cascades. We will also discuss a set of novel findings on the molecular crosstalk 
between VacA and CagA. 
2. VacA Expression, Secretion, Maturation and Allelic Variation 
An early work by Leunk and colleagues [29] discovered that broth-culture supernatants of Hp 
strains contained a proteinaceous cytotoxin that induced cytoplasmic vacuolation when incubated with 
eukaryotic cells in vitro. Multiple cell types from human and animal species were susceptible to its 
toxic activity, albeit with great differences. The structural organization of VacA closely resembles that 
of IgA protease-like factors secreted by pathogenic Neisseriae and Haemophilus species [9], which are 
today known as the autotransporter or type V secretion family of proteins [18]. Like many other 
classical autotransporters, VacA contains a 33-amino acid signal sequence and undergoes cleavage 
during the transport across bacterial membranes (Figure 1). VacA genes are predicted to encode a 
translated protein of about 135–145 kDa depending on the strain. However, VacA proteins of this 
molecular weight have never been reported [8]. Instead, three VacA protein spots of the Hp strain 
26695 were identified by two-dimensional gel electrophoresis (2-DE). The most predominant VacA 
protein spots on 2–DE gels were approximately 95.7 kDa and 87.9 kDa in size, and were found both in 
fractions of the Hp membrane and culture supernatant [30,31]. In addition, a 10.5 kDa VacA spot was 
found in the secreted protein fraction [30]. Mass spectrometry of the identified peptides are consistent 
with a model that the 95.7 kDa VacA protein is the secreted toxin which is then cleaved into the  
87.9 kDa mature protein (p88) and the 10.5 kDa passenger domain (p10, also known as the alpha-
protein) (Figure 1). The exact cleavage site between p88 and p10 was detected between position 991 
and 992 [30]. The processed beta-domain of the autotransporter subunit was not detected by 2–DE, but Toxins 2010, 2 
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has been observed in total cell lysates [32]. However, the mature translocated p88 domain can undergo 
further proteolytic cleavage to yield two fragments, known as p33 and p55 (Figure 1, bottom). The 
latter two processing products are believed to represent the functional domains of VacA (see below). 
Thus, VacA may exhibit some properties resembling those of classical A/B-toxins. Interestingly, while 
cleavage between p33 and p55 subunits has been seen in vitro [33], no cleavage in vivo could be 
detected [34]. A possible explanation is that the rate of VacA cleavage in vivo is too low to be 
observed. In some studies, VacA and its domains have slightly different sizes, but we will use the p33 
and p55 nomenclature throughout this review. However, the basis of vacA size and sequence variation 
was found in several alleles that have been identified in the signal region (genotypes s1 and s2) and in 
the mid region (genotypes m1 and m2), occurring in all possible combinations [1,7–9]. In addition, 
two intermediate region variants (called i1 and i2) were identified as other important determinants of 
VacA toxicity [35]. VacA proteins of the s2 type are inactive in assays for the vacuolating phenotype, 
while type s1/ml alleles produce extensive vacuolation in a large array of cell categories and type 
s1/m2 allels induce detectable vacuolation in a more limited range of cell types, which is in 
concurrence with its location in p55 as the cellular binding domain of VacA [36,37]. 
Figure 1. VacA domain structure and processing products. The amino-terminal signal 
sequence (SS) and carboxy-terminal domain are cleaved from the full-length 135–140 kDa 
VacA protein to yield a 98 kDa secreted toxin (p98) that is transported into the 
extracellular space via the autotransporter mechanism. Proteins of this autotransporter 
family are able to mediate their own secretion without the need of additional bacterial 
proteins. The 33 kDa carboxy-terminal beta-barrel domain of VacA is predicted to insert 
into the outer membrane and to form a channel, through which the mature VacA toxin is 
secreted. The secreted toxin can be processed into the mature toxin (p88) and p10. The 
mature, secreted p88 subunit can undergo further limited proteolytic cleavage to yield two 
additional fragments, p33 and p55 [7,8,32]. The latter two processing products are 
considered to represent the functional domains or subunits of VacA. 
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3. Domains of VacA and Crystal Structure of the p55 Subunit 
In response to acidic pH, VacA undergoes a structural change, which increases its cellular activity 
and renders it resistant to proteolysis by pepsin [38]. The relevance of the pH, however, is still not 
fully understood because VacA has also been shown to be activated at alkaline pH [39]. In fact, it 
appears that only highly purified VacA is poorly active and needs to be activated by pH change, but 
this is not necessary during infection or when VacA is simply collected from the bacterial supernatant 
(broth culture filtrate). Thus, VacA secreted by the bacteria is most likely fully active independently of 
the luminal gastric pH. This is in agreement with the fact that the mucus layer close to the gastric 
epithelium, in which Hp resides, is at a mild acidic pH. However, the secreted p88 subunit of VacA 
can assemble into water-soluble oligomeric structures [33,40], and can insert into planar lipid bilayers 
to form anion-selective membrane channels [41–43]. These structures resemble a flower-like 
configuration (Figure 2B). Interestingly, low pH treatment of these oligomeric structures break them 
apart releasing VacA monomers [40]. The first reported high-resolution images were 19–Å cryo 
electron microscopy maps of VacA dodecamers [44], and atomic-force microscopy and 
electrophysiological studies implied that VacA membrane channels are single-layered structures 
[41,43]. When the p33 and p55 domains are expressed separately and then mixed, p33 and p55 can 
physically interact and restore vacuolating activity in epithelial cells [45–47]. The p33 subunit contains 
a hydrophobic stretch (amino acids 6–27) which is involved in pore formation and/or membrane 
insertion [48,49], whereas p55 contains one or more cell interaction sites [36,37,50]. Recently, the  
2.4-Å crystal structure of p55 has been published [51]. The structure is predominantly a right-handed 
parallel β-helix, a feature which is characteristic of autotransporter passenger subunits but unique 
among other known toxins (Figure 2A-C). Notable features of p55 include disruption of β-sheet 
contacts which result in five β-helix subdomains and a carboxy-terminal domain that contains a 
disulfide-bond. Gangwer et al. [51] proposed an oligomerization model in which p33 interacts with the 
amino-terminal portion of p55 from the neighboring subunit. Regions of contact between p33 and p55 
are depicted with dashed lines (Figure 2B, right structure). On the left in Figure 2C, the upper circle 
highlights three loops that mediate p55–p55 contacts between the two layers. The lower circle 
indicates the two loops that line the conserved pocket that were proposed as a common receptor-
binding site [51]. This pocket is located on the side of the molecule and would therefore be accessible 
in both single-layered and bilayered forms of the toxin. The circle in the middle contains the other 
conserved surface in p55. This surface protrudes into the central ring of the VacA oligomer and would 
be accessible to the molecule for contacts that could mediate oligomerization within a hexameric or 
heptameric plane. The enlarged section to the right in Figure 2C shows the secondary structures that 
contribute to this surface. Again, p55 contains the aforementioned m1/m2 alleles, and investigation of 
VacA sequences from unrelated Hp strains allowed the identification of structural surface features 
which may be important for interactions with host cell receptors [51]. 
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Figure 2. Molecular structure of VacA. (A) The p55 domain of VacA adopts a β-helix 
structure that is composed of three parallel β-sheets connected by loops of varying length 
and structure [51]. The carboxy-terminal domain contains a mixture of α/β secondary 
structure elements and contains a disulfide bond. The carboxy-terminus of the β-helix 
(right, rotated by 90°) is capped by a β-hairpin from the carboxy-terminal domain and the 
α1−helix located in one of the long helix loops. (B) Docking the p55 crystal structure into 
a 19-Å cryo electron microscopy map of the VacA dodecamer results in a model for 
oligomerization. Twelve p55 subunits are shown docked into a 19-Å cryo-EM map of a 
VacA dodecamer [44]. An arrow is shown to indicate the space that the upper molecule 
will occupy if p33 extends the β-helix structure of p55. The inset shows EM images of a 
VacA hexamer and a VacA monomer [44]. The shape of a VacA hexamer (inset) is similar 
to the shape of a single layer within the dodecamer [44]. The rod-like shape of the p88 
monomer (inset) supports a model in which the β-helix of p55 will extend into p33.   
(C) The view from the left structure in panel B is rotated by 90°. This figure was kindly 
provided by Dr. Borden Lacy and originally published by Gangwer et al. [51] with kind 
permission of the National Academy of Sciences, USA. 
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4. VacA Targets Various Surface Factors Both on Epithelial and Immune Cells 
The cellular effects of VacA have been investigated intensively both in vivo and  in vitro. A 
simplified model for the complex interactions of VacA with multiple cell types and downstream 
signalling cascades is presented in Figure 3A-L, while known host cell binding partners are 
summarized in Table 1. Like many other bacterial toxins, VacA interacts with the plasma membrane of 
susceptible cells as a first step during intoxication (Figure 3A). Following cell binding, VacA is 
internalized by a pinocytic-like and clathrin-independent mechanism [52,53]. A remarkable feature of 
VacA is that it can target multiple cell-surface components in vitro or on epithelial cells including 
RPTP-alpha [54], RPTP-beta [39,55], various lipids [56,57,41], heparin sulphate [58], sphingomyelin 
[59], fibronectin [60], the epidermal growth factor receptor (EGFR) [61] as well as integrin β2 (CD18) 
on T cells [62]. Determining which of these factors is required for VacA uptake and subversion of 
cellular signalling has been a challenging topic of research and is still not fully studied for each factor. 
However, the importance of RPTP’s for VacA-dependent activities has been investigated in much 
detail. For example, VacA causes gastric injury in wild-type mice but not in the RPTP-beta knockout 
mice [55]. This indicates that interaction of VacA with RPTP-beta on the surface of gastric epithelial 
cells is mechanistically important in VacA-induced gastric injury. Remarkably, VacA can still induce 
vacuolation in cultured gastric epithelial cells from RPTP-beta knockout mice or in G401 human 
kidney cells, which do not express RPTP-beta [54,55], but inhibition of RPTP-beta expression by 
silencing oligonucleotides in HL-60 cells downregulated VacA-induced vacuolation [63]. These data 
suggest that RPTP-beta exhibits crucial functions in the process of VacA-induced signalling but not 
necessarily vacuolation itself. Addition of VacA to target cells has been also shown to induce the 
tyrosine phosphorylation of G-protein-coupled receptor-kinase-interacting protein-1 (Git-1) and lipid-
raft dependent downstream signalling [55,64]. In line with these observations, VacA was reported to 
bind to the QTTQP-motif in the extracellular domain of RPTP-beta, which was also necessary for 
inducing Git-1 phosphorylation [54]. Another reported consequence of VacA-binding to RPTP-beta is 
detachment of primary murine gastric epithelial cells from the extracellular matrix [55]. Furthermore, 
VacA has been shown to interact with lipid preparations and artificial membranes, but the specificity 
and importance of VacA-lipid interactions for toxin function was unknown until recently. A new study 
provided evidence that sphingomyelin modulates the sensitivity of epithelial cells to VacA [59]. 
Sphingomyelin is a key structural component of the cell membrane (in particular lipid rafts), while at 
the same time serving a functional role, as it is the parental compound of various lipid mediators. In 
fact, sphingomyelin was shown to be required for VacA’s association with lipid rafts on the plasma 
membrane and binding to cells, suggesting that sphingomyelin functions as a receptor molecule of 
VacA on the epithelial cell surface [59]. However, VacA does not only interact with gastric epithelial 
cells, but also with immune cells including B cells, T cells and macrophages (Figure 3J-L). 
Interestingly, VacA efficiently enters activated, migrating primary human T lymphocytes by binding to 
the integrin β2 (CD18) receptor and exploiting the recycling of LFA-1, the lymphocyte function-
associated molecule-1 [62]. LFA-1-deficient Jurkat T-cells were resistant to vacuolation, and genetic 
complementation of LFA-1 restored the sensitivity of cells to VacA. Remarkably, VacA targeted 
human CD18 for cell entry, but not its murine counterpart. These findings are consistent with the 
species-specific adaptation of Hp in its human host [62]. Toxins 2010, 2 
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Table 1. Host binding partners of VacA and proposed function 
a. 
VacA 
binding 
partners 
Proposed role in VacA-
host interactions 
Methods used  Experimental 
evidence
b 
Reference 
EGF 
receptor 
Receptor on epithelial 
cells 
Antibody blocking, IP  Infection in vitro [61] 
Fibronectin Binding  of  H. pylori to 
host cells 
Binding and cell 
adhesion and assays 
Binding in vitro [60] 
Glycosphin
golipids 
Binding partner for VacA 
internalization 
Binding assays, 
Chromatography, MS 
Binding in vitro [65] 
Heparin 
sulphate 
Receptor/co-receptor on 
epithelial cells 
SPR-based biosensor 
studies 
Binding in vitro [58] 
Integrin β2 
(CD18) 
 
Receptor on T cells  Flow cytometry, IF, 
live cell imaging, use 
of knockout cells 
Treatment of cells 
in vitro, 
Infection in vitro 
[62] 
Lipid 
bilayers 
Low pH-triggered pore 
formation 
AFM Binding  in vitro [41] 
Lipid rafts  Putative docking and 
entering site at cell 
surface 
Cell fractionation, 
flow cytometry, IF, 
MCD inhibitor studies 
Treatment of cells 
in vitro 
[66] 
[67] 
[64] 
Lipid 
vesicles 
Binding and host cell 
entry of the toxin 
Light scattering, 
energy transfer studies
Binding in vitro [56] 
Phospho- 
lipids 
Binding and host cell 
entry of the toxin 
ANS-binding studies, 
Photolabelling 
 
Binding in vitro [57] 
RPTP-
alpha 
Receptor on epithelial 
cells 
IP, MS, antisense 
silencing studies 
Infection in vitro, 
Treatment of cells 
in vitro 
[54] 
[68] 
RPTP- 
beta 
Receptor on epithelial 
cells, receptor for Git1 
phosphorylation 
Flow cytometry, IF, 
IP, siRNA, use of 
knockout mice and 
cells 
Binding in vitro, 
Infection of mice 
and cells 
 
[39] 
[63] 
[55] 
RACK-1  Yet unknown  PD, Y2H  Binding in vitro [69] 
Sphingo-
myelin 
Receptor on epithelial 
cells 
Binding studies, 
ELISA, flow 
cytometry, treatment 
with 
sphingomyelinase 
Binding and 
treatment of cells 
in vitro 
[59] 
a Abbreviations used: ANS (1-Anilino-8-naphtalensulfonate), AFM (atomic force microscopy), EGF 
(epidermal growth factor), ELISA (enzyme-linked immunosorbent assay), IF (co-localization by 
immunofluorescence), IP (immunoprecipitation), MCD (methyl-β-cyclodextrin), MS (mass spectrometry), 
PD (pull-down), siRNA (silencing RNA knockdown), SPR (surface plasmon resonance), Y2H (yeast two-
hybrid). For other abbreviations, see text. 
b Term explanation: Binding in vitro (purified and/or recombinant VacA was incubated with the factor of 
interest in vitro); Infection in vitro (Hp infection of cultured host target cells); Infection of mice (infection of 
wild-type and knockout mice); Treatment of cells in vitro (purified or recombinant VacA was applied 
externally to cultured host cells in vitro, and then binding of the factor of interest was investigated). Toxins 2010, 2 
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5. VacA Activities on Endosomal Maturation and Cell Vacuolation 
As mentioned above, the first identified activity of VacA was its ability to induce vacuolation in 
numerous eukaryotic cell types [29]. A current model for vacuole formation suggests that VacA binds 
to the plasma membrane of host cells, forms anion-selective channels in the plasma membrane, 
becomes internalized into endosomes and the vacuoles finally arise by swelling due to osmotic 
imbalance of the late endosomal compartments (Figure 3C). In fact, VacA-induced vacuoles constitute 
hybrid compartments of late endosomal origin that contain some lysosomal markers, and their 
formation strictly depends on the presence of weak bases such as ammonia, which can be provided by 
urease activity [34,70]. To achieve this goal, VacA is first pinocytosed in a manner dependent on the 
small Rho GTPase Cdc42 [53], and is subsequently routed into early endosomal compartments which 
are enriched with glycosylphosphatidylinositol (GPI)-anchored proteins  [52,53]. These early 
endosomes are  also associated with dynamic polymerised (filamentous) actin structures [71]. The 
CD2-associated protein (CD2AP), a docking protein implicated in intracellular trafficking, bridged the 
filamentous actin with early endosomes containing VacA. Interestingly, CD2AP regulated these actin 
structures and was required to transfer VacA from early to late endosomes and vacuolation [71]. 
Vacuole formation further depends on the presence and activity of a number of other signalling factors 
including V-ATPase [72], Rab7 [73] and Rac1 [74]. Recent studies showed that at least the role of 
Rac1 in vacuole formation is due to the fact that Rac1 is required for binding of VacA to the cell 
membrane [53]. However, protein kinase PIKfyve is also necessary for vacuole production, and 
microinjection of its substrate phosphatidylinositol-3,5-bisphosphate (PIP2) was demonstrated to be 
sufficient for vacuole formation [75], whereas involvement of the SNARE protein syntaxin-7 is 
controversial [76,77]. Also, the role of dynamin in large VacA-dependent vacuole formation is 
controversial. Dynamin has been shown to play either no role [52] or is fully necessary for cell 
vacuolation [78]. When expressed intracellularly, the minimum segment of VacA required for 
vacuolating activity comprises the entire p33 subunit and about 110 amino acids from the amino-
terminus of p55 [45,79]. Vacuolating activity also requires di- or oligomerization of VacA [80,81] and 
depends on the hydrophobic amino-terminus (about 30 amino acids) containing three tandem 
GXXXG-sequences which are transmembrane dimerization motifs [49,82]. These requirements 
suggest that channel formation is a prerequisite for vacuolation. This conclusion is also supported by 
the observation that small anion-channel inhibitors effectively block vacuole production [83]. 
6. Amino-Terminal VacA Targets Mitochondria to Induce Apoptosis 
Infection of epithelial target cells with Hp has been associated with both increased and reduced 
levels of apoptosis [1,2,7]. In vitro, Hp reproducibly stimulates apoptosis in infected gastric epithelial 
cells, and this has also been seen in tissues isolated from infected patients or animal models [1,2]. 
Early studies indicated that purified VacA induced mitochondrial damage as indicated by a significant 
drop in ATP levels within cells [84], and was then discovered to induce apoptosis by a mitochondrial 
pathway [85]. In the latter study, HEp-2 cells were transfected with different VacA constructs, and the 
p33 subunit was found to localize specifically to mitochondria, whereas p55 remained cytosolic. When 
purified VacA was co-incubated with isolated mitochondria, p33 (but not p55) was translocated into 
these organelles. In addition, transient expression of p33-GFP or full-length VacA-GFP in HeLa cells Toxins 2010, 2 
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induced the dramatic release of cytochrome c from mitochondria and activated apoptotic caspase-3 
(Figure 3F), as determined by the cleavage of poly-ADP-ribose polymerase, PARP. Cleavage of PARP 
was antagonized specifically by co-transfection of DNA vectors expressing Bcl-2, a factor known to 
inhibit mitochondria-associated apoptotic signals [85]. These observations were further supported by 
infection studies using wild-type Hp and ΔvacA mutant strains [86,87]. Remarkably, the s1/m1 allel of 
VacA induced high levels of apoptosis while s2/m1 toxin and truncated VacA mutants lacking the 
hydrophobic region near the amino-terminus did not. These results suggest that VacA can trigger 
gastric epithelial cell apoptosis and implicate that differences in levels of gastric mucosal epithelial 
apoptosis among Hp-infected individuals may arise from strain-dependent vacA sequence variation. 
Interestingly, studies in MKN-28 cells showed that, unlike cell vacuolation, neither apoptosis nor 
change of mitochondrial transmembrane potential induced by VacA require ammonia [88]. The latter 
findings make unlikely the hypothesis that ammonia-dependent swelling and rupture of endosomal 
vesicles in which VacA is sequestered after cellular uptake may allow the toxin to reach mitochondria 
and trigger apoptosis, and therefore requires a different pathway. 
7. VacA and Other Factors Affecting the Transepithelial Resistance of Polarized Cell 
Monolayers 
An important feature of intact polarized cells is the development of transepithelial electrical 
resistance (TER), a measurable indicator of epithelial integrity. When purified VacA (acid-activated) 
was incubated with polarized host cell monolayers, it was shown to decrease TER significantly [89] 
and may contribute to epithelial barrier disruption induced by Hp (Figure 3E). This effect was 
confirmed in several types of polarized epithelial cells including EPH4, T84 and MDCK and during 
infection. The latter effect was independent of VacA’s vacuolating activity as it was also seen with 
m2-alleles of VacA [90]. It was proposed that selective permeabilization of polarized epithelial 
monolayers by VacA may lead to the release of certain molecules such as Ni
2+, Fe
3+, sugars and amino 
acids, which might support the growth of Hp within the gastric mucus [89,90]. As yet, the mechanism 
by which VacA alters paracellular permeability is little understood. However, it has also been noted 
that VacA increases the transepithelial flux of certain molecules such as urea the substrate of Hp 
urease [91]. The release of urea from cells, however, is attributed to the formation of VacA channels in 
the plasma membrane. Other studies have indicated that disruption of cell-to-cell junctions in polarized 
MDCK cells required VacA but also a second factor, injected CagA (Figure 3E), which targets both 
tight and adherens junctions [20,92]. In contrast, it was shown that incubation of polarized T84 
epithelia by VacA prepared from broth culture filtrate of Hp did not modify the TER of the epithelia 
[93]. More complexity arises from another recent study showing that Hp induced a progressive loss of 
barrier function in INS-GAS mice and MKN-28 gastric epithelial cells, which was attenuated by 
inactivation of the ΔureB gene, but not ΔvacA or ΔT4SS genes [94]. Remarkably, Hp induced the 
deregulation of specific tight junction proteins, including phosphorylation of MLC (myosin regulatory 
light chain) by MLC kinase and internalization of occludin. Thus, epithelial barrier disruption by Hp is 
a highly complex scenario, requiring various bacterial factors and signalling pathways which still need 
to be investigated in more detailed future studies [95]. Toxins 2010, 2  
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Figure 3. Model of the various activities of VacA to induce altered host cell signalling in epithelial and immune cells which contributes to 
persitent Hp colonization in the human stomach. 
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8. VacA Elicits Suppressive Activities on Immune Cell Proliferation 
During the long co-evolution of Hp with humans, the bacteria  have accumulated numerous 
strategies to circumvent host immune cell functions. Some of these functions have been attributed to 
VacA (Figure 3J-L). A pioneering early study demonstrated that VacA can inhibit processing and 
presentation of antigenic peptides to human CD4-positive T cells (Figure 3J), and suggested for the 
first time that VacA may contribute to the persistence of Hp by interfering with protective immune 
responses [96]. In infected professional phagocytes, such as mouse RAW 264.7 and human THP-1 
macrophage-like cell lines, wild-type Hp exhibited enhanced survival as compared to vacA deficient 
mutants [97]. Therefore, it appears that VacA can arrest phagosome maturation by recruiting and 
retaining coronin-1 or TACO, the tryptophane aspartate-containing coat protein (Figure 3K). In 
addition, it was shown that VacA can inhibit the expression of endothelial nitric oxygen synthase 
(eNOS) which resulted in significantly less production of reactive oxygen species (ROS) in 
monocyte/macrophage-like U937 cells and enhanced survival of VacA-positive Hp (Figure 3J). The 
detected pathway involved a suppressive effect of VacA on the expression of ILK (integrin-linked 
kinase), which provided a direct link to eNOS downsteam of ILK [98]. However, enhanced survival of 
isogenic ΔvacA mutants as compared to their wild-type strains was not seen in two other reports when 
freshly isolated human monocytes were infected [99,100]. The latter differences may be attributed to 
varying infection doses, cell types or Hp strains carrying different vacA alleles. 
Co-incubation of purified VacA with or infection of T lymphocytes yields multiple effects. For 
example, VacA can specifically block the antigen-dependent proliferation of Jurkat T cells by 
interfering with IL-2-mediated signalling [101,102]. As discussed above, Hp targets CD18 (β2 
integrin) as the receptor of VacA on human T lymphocytes [62]. After entry, VacA inhibits Ca
2+ 
mobilization and, subsequently, downregulation of the activity of the Ca
2+-dependent phosphatase 
calcineurin. This in turn inhibits the activation of transcription factor NFAT (nuclear factor of 
activated T cells). As a consequence, NFAT target genes such as IL-2 and the high-affinity IL-2 
receptor (IL-2R-alpha) are not expressed anymore (Figure 3L). VacA, however, exerts a different 
effect on primary human CD4-positive T cells, whose proliferation is inhibited through the T cell 
receptor (CD28) and eventually by other VacA activities [103]. In the latter study, VacA was shown to 
suppress IL-2-induced cell cycle progression and proliferation of primary T cells without affecting 
NFAT. Therefore, VacA may inhibit the clonal expansion of T cells that have been activated by 
numerous bacterial antigens. This in turn would allow Hp to evade adaptive immune responses which 
can permit persistent infection.  
9. VacA-Dependent Pro-Inflammatory Signalling Activities 
Numerous  Hp factors have been implicated in the induction of gastric inflammation. Besides 
peptidoglycan [14], OipA [13] and CagA [21], VacA has now also been found to activate pro-
inflammatory responses during infection with Hp. For example, addition of VacA to the gastric 
adenocarcinoma cell line AZ-521 activates two classes of MAP kinases (p38 and Erk-1/2) and the 
activating transcription factor 2 (ATF-2) signalling pathway [104, Figure 3B]. Pharmacological 
inhibition of p38 kinase activity, however, did not block the vacuolation phenotype or mitochondrial 
damage, which indicates that VacA-induced activation of the p38/ATF-2 signalling cascade is Toxins 2010, 2  
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independent of endosomal and mitochondrial pathways of VacA [104]. VacA has also been reported to 
induce activation of p38 in several other types of cells [102] and U937 macrophage-like cells [105]. In 
the latter study, VacA-induced p38 activation in U937 cells revealed a prominent role in stimulation 
IL-8 production via ATF-2, cAMP response element binding (CREB) protein and nuclear transcription 
factor kappa B (NF-κB). Interestingly, VacA can also induce NF-κB in T cells [106], thus the toxin 
obviously has two paradoxical activities on T cells, immunosuppression and pro-inflammatory effects 
(Figure 3J). In addition, in neutrophils and macrophages, VacA treatment can stimulate the expression 
of Cox-2 (cyclooxygenase-2), a pro-inflammatory enzyme [102]. The expression of Cox-2 is mediated 
by VacA-induction of p38 and also enhanced the secretion of prostaglandin E2 [105]. In another cell 
culture model, binding of VacA to RBL-2H3 mast cells resulted in a rapid change in cytosolic Ca
2+ 
concentrations [107]. This was accompanied by stimulation of pro-inflammatory cytokines (including 
IL-6 and TNF-α), resulting in chemotaxis and degranulation of these mast cells [107,108].  
10. Molecular Crosstalk between VacA and CagA Signalling Pathways 
Several recent studies have demonstrated that VacA does not act independently of other bacterial 
colonization or virulence factors. There are four prime examples of molecular crosstalk between 
VacA, CagA and the T4SS affecting multiple responses including Hp-induced apoptosis, cell 
vacuolation, cell elongation, NFAT signalling and EGFR activation, which will be discussed below. 
10.1. Role of VacA and CagA in Apoptotic and Anti-Apoptotic Signalling 
As described above VacA can target mitochondria and induce apoptotic cell death in vitro. 
However, for gastric cell apoptosis in vivo, several other parameters are likely to be important. Under 
normal conditions, rapid self-renewal of the gut epithelium, which occurs by a balance of progenitor 
proliferation and pit cell apoptosis, serves as a host defence mechanism to limit bacterial colonization. 
In the Mongolian gerbil (Meriones unguiculatus) model system, it was shown that Hp inhibits the 
apoptotic loss of pit cells [22]. Suppression of apoptosis contributed to pit hyperplasia and persistent 
bacterial colonization of the stomach, and this was mediated by injected CagA which stimulated the 
pro-survival mitogen-activated protein (MAP) kinase member Erk-1/2 and anti-apoptotic protein 
MCL-1 in the gastric pits. Thus, it appears that CagA counteracts VacA signalling and activates anti-
apoptotic and host cell survival signal cascades to overcome self-renewal of the gastric epithelium and 
contribute to chronic Hp infection [22]. In a very recent study, the transfected carboxy-terminal 
domain of CagA (38 kDa) inhibited VacA-induced apoptosis by two complementary mechanisms 
[109]. Tyrosine-phosphorylated CagA prevented pinocytosed VacA to reach its target intracellular 
compartments. Unphosphorylated CagA triggered an anti-apoptotic activity blocking VacA-induced 
apoptosis at the mitochondrial level without affecting the intracellular trafficking of the toxin. These 
results were confirmed during infection with Hp and it was proposed that, once bacteria have 
colonized the gastric niche, the apoptotic action of VacA might be detrimental for the survival of Hp 
adherent to the mucosa. Thus, CagA association with VacA maybe a novel, highly ingenious microbial 
strategy to locally protect its ecological niche against a bacterial virulence factor, with however 
detrimental consequences for the human host [109].  
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10.2. Role of VacA and CagA in NFAT Signalling 
It has been demonstrated that CagA and VacA have opposing effects in T cells, for example on the 
activation of transcription factor NFAT [110]. A genome-wide screening of CagA-responsive genes 
using DNA microarrays identified NFAT transcription factors whose binding sites were 
overrepresented in the promoter regions of CagA-activated genes. The results of reporter assays 
confirmed that CagA was capable of activating NFAT in a manner independent of CagA 
phosphorylation. Expression of CagA in gastric epithelial cells provoked translocation of NFATc3, a 
member of the NFAT family, from the cytoplasm to the nucleus and activated an NFAT-regulated 
gene, p21WAF1/Cip1. CagA-mediated NFAT activation was abolished by inhibiting calcineurin or 
phospholipase C-gamma activity. Furthermore, treatment of gastric epithelial cells with purified VacA, 
which inhibits NFAT activity in T lymphocytes [101], counteracted the ability of CagA to activate 
NFAT [110]. These findings indicate that the two major Hp virulence factors inversely control NFAT 
activity. Considering the pleiotropic roles of NFAT in cell growth and differentiation, deregulation of 
NFAT, either positively or negatively, depending on the relative exposure of cells to CagA and VacA, 
may contribute to the various disease outcomes caused by Hp infection.  
10.3. Role of VacA and CagA in the Vacuolation and Cell Elongation Phenotypes 
It has been demonstrated in vitro that VacA can negatively regulate the CagA-induced elongation 
phenotype, and CagA can downregulate VacA-induced cell vacuolation [111,112]. In particular, 
isogenic ΔcagA and T4SS-deficient Hp mutants were found to significantly increase VacA-induced 
vacuolation of AGS gastric epithelial cells, and the ΔvacA mutants significantly increased the CagA-
induced cellular elongation phenotype as compared with their wild-type strains. Although AGS cells 
incubated with the wild-type Hp strains may display both vacuolation and elongation phenotype 
formation, it was found that (i) the length of elongated cells was significantly reduced in vacuolated 
cells compared with those without vacuolation; (ii) the number of vacuoles was significantly reduced 
in elongated cells; and (iii) cells displaying extensive vacuolation did not subsequently elongate and 
vice versa. Importantly, VacA did not affect the phosphorylation of CagA [111,112]. These data 
indicate that VacA and CagA can downregulate each other's phenotypical effects on AGS   
epithelial cells. 
10.4. Role of VacA and T4SS in Epidermal Growth Factor Receptor (EGFR) Signalling 
Another recent study indicated that the T4SS and VacA have opposing effects on the activation of 
members of the EGFR family kinases during infection with Hp [112]. Early studies have demonstrated 
that Hp can activate EGFR in a T4SS-dependent manner [24,25], and that addition of purified VacA or 
VacA-positive culture supernatants had suppressive effects on proliferation, migration or wound 
healing of gastric epithelial cells in vitro [113–116]. In the latter studies it was shown that VacA can 
block the activity of externally added EGF. These findings suggest that VacA may interfere with 
EGFR receptor signalling and cell proliferation (Figure 3G,H). Indeed, preparations of VacA or 
infection with VacA-expressing Hp exhibited suppressive effects on the phosphorylation and 
consequently activation of EGFR [112,114] and HER2/Neu, another member of the EGFR family Toxins 2010, 2  
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[112]. Immunofluorescence data showed internalized EGFR in infections with VacA-expressing Hp, 
providing a possible mechanism for how significant portions of EGFR are inactivated by VacA [112]. 
Interestingly, RPTP-alpha but not vacuolation per se played a role in this process. In addition, it was 
shown that EGFR-mediated Erk-1/2 activation is necessary for the CagA-induced elongation 
phenotype (Figure 3I), which can be suppressed in infection with Hp strains expressing highly active 
VacA [112]. Although further investigation is necessary, these data clearly demonstrate that VacA can 
downregulate CagA's effects on epithelial cells, a novel molecular mechanism showing how Hp may 
avoid excessive cellular damage during infection, which may also contribute to ensure persistent 
infection.  
11. Other VacA-Dependent Signalling Activities 
In addition to the VacA-triggered activities described above, several other features have been 
described. For example, Yeast two-hybrid (Y2H) screens and other experiments have demonstrated 
VacA’s potential for specific binding to the receptor for activated C kinase-1, Rack-1 (Table 1), 
however, its function for the infection process is widely unknown [69]. The effect of the toxin on 
endosomal and lysosomal functions was also studied by following procathepsin-D maturation and 
EGF degradation in HeLa cells exposed to VacA. Interestingly, VacA blocked cleavage of 
procathepsin-D (53 kDa) into both the intermediate (47 kDa) and the mature (31 kDa) form, and 
intracellular degradation of EGF was also inhibited [117]. These findings suggest that VacA can also 
impair the degradative power of late endosomes and lysosomes. Finally, further complexity in the 
overall scenario arises from the observation that VacA can also activate the beta-catenin signalling 
pathway [118]. Incubation of AZ-521 cells with VacA resulted in phosphorylation of protein kinase B 
(Akt) and glycogen synthase kinase-3beta (GSK3beta) through a phosphoinositide-3-kinase (PI3K)-
dependent pathway. Following phosphorylation and inhibition of GSK3beta, beta-catenin was released 
from a GSK3beta/beta-catenin complex, with subsequent nuclear translocation. Inhibitor studies 
indicated that VacA-induced phosphorylation of Akt does not require VacA internalization and is 
independent of vacuolation. In contrast, infection with a ΔvacA mutant failed to induce 
phosphorylation of Akt and GSK3beta, or release of beta-catenin from a GSK3beta/beta-catenin 
complex [118]. These results support the hypothesis that VacA activates the PI3K→Akt signalling 
pathway, resulting in phosphorylation and inhibition of GSK3beta. Subsequent translocation of beta-
catenin into the host cell nucleus is consistent with effects of VacA on beta-catenin-regulated 
transcriptional activity and a new possible role in the pathogenesis of Hp, including the development 
of gastric cancer. Thus, VacA is a highly fascinating bacterial toxin with multiple signalling activities.  
12. Conclusions 
Hp is the most common chronic bacterial infection worldwide, and, although asymptomatic in the 
majority of infected persons, it is also the cause of significant rates of morbidity and mortality. The 
interest in this field is underlined by more than 28,000 scientific publications that have appeared in 
PubMed since its discovery in 1982. However, Hp infection occurs in approximately half of the world 
population, with disease being an exception rather than the rule. Understanding how this organism 
interacts with its host is essential for formulating an effective strategy to deal with its most important Toxins 2010, 2  
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clinical consequences. Studies of host-bacterial interactions and bacterial virulence factors in this 
infection model have provided important insights for clinical practice. Research over the past decade 
on VacA, CagA and the T4SS has provided us with fundamental insights into Hp biology and has 
generated a complex and often puzzling scenario. VacA is secreted into the extracellular space and 
also is, at least in part, retained on the bacterial cell surface. The toxin exists in monomeric and 
oligomeric forms, and binds to multiple host cell surface receptors. We have discussed here the 
cellular effects induced by VacA which include pore formation in the plasma membrane, alteration of 
endo-lysosomal function, vacuolation, apoptosis and immune cell inhibition. VacA has been 
demonstrated to target several different cell components, including endocytic vesicles, the actin-
cytoskeleton and mitochondria. However, it still remains unclear whether VacA has an enzymatic 
activity, and if it should be categorised as an A/B-type toxin, a pore-forming toxin or both. In addition, 
it appears that there is substantial molecular crosstalk between VacA and CagA signalling cascades 
during infection both in epithelial and immune cells. These novel findings further highlight the 
enormous complexity in Hp-host cell interactions. Thus, it appears that Hp‘s virulence factors will 
continue to be a fascinating and rewarding research subject in future studies. 
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